Entering text into the input field will update the search result below

OpGen shares rise after Q2 results, regulatory timeline update

Aug. 12, 2021 4:43 PM ETOpGen, Inc. (OPGN) StockBy: SA News Team

Testing, verification and determination of pharmaceutical, drug quality, concept
Zhanna Kavaliova/iStock via Getty Images

  • OpGen (NASDAQ:OPGN) shares rise more than 3% post market after the company reports Q2 results and provides an update on regulatory timelines.
  • The company said that it is still waiting for the FDA to complete its review

Recommended For You

More Trending News

About OPGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OPGN--
OpGen, Inc.